PCV101 Japanese Patients and Physicians Preferences for Anticoagulants Use in Atrial Fibrillation - Results From a Conjoint-Analysis Study

Kazuhiro Okumura(Tenri Hospital), J Brière(Bayer (Japan)), B Rossi(Bayer (Japan)), Kazuya Iwamoto(Osaka Police Hospital), Brett Hauber(Pfizer (United States)), Juan Marcos González(Clinical Research Institute), Bennett Levitan(Johnson & Johnson (United States)), Zuyi Yuan(First Affiliated Hospital of Xi'an Jiaotong University), Masahiro Yasaka(Ohkawara Neurosurgical Hospital), Hiroshi Inoue(Toyama University Hospital), E.C.Y. Wang(Bayer (Japan))
Value in Health
October 29, 2012
10.1016/j.jval.2012.08.1044
Cited by 3

Related Papers

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.
|Journal of Clinical Investigation|1989|240
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
|Mayo Clinic Proceedings|2007|238
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
|The Lancet|2023|139
Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.
|Journal of Clinical Investigation|1989|133